Authorization of Series B Notes. The Series B Notes have been duly authorized by each of the Issuers and, when issued in the Registered Exchange Offer, (A) will have been validly executed, authenticated, issued and delivered in accordance with the terms of the Indenture, the Registration Rights Agreement and the Registered Exchange Offer and (B) will be legal, valid and binding obligations of each of the Issuers, entitled to the benefits of the Indenture and enforceable against each of the Issuers in accordance with their terms, except to the extent that (i) such enforceability may be limited by applicable bankruptcy, insolvency or similar laws affecting creditors' rights generally and (ii) any rights of acceleration and the availability of equitable remedies may be subject to general principles of equity (whether considered in a proceeding in equity or at law).
Authorization of Series B Notes. The Series B Notes have been duly authorized by the Company and, if and when issued in the Registered Exchange Offer, and executed by the Company and authenticated by the Trustee, (A) will have been validly executed, authenticated, issued and delivered in accordance with the terms of the Indenture, the Registration Rights Agreement and the Registered Exchange Offer and (B) will be legal, valid and binding obligations of the Company, entitled to the benefits of the Indenture and enforceable against the Company in accordance with their terms, except to the extent that (i) such enforceability may be limited by applicable bankruptcy, reorganization, insolvency, moratorium or similar laws affecting creditors’ rights generally and (ii) any rights of acceleration and the availability of equitable remedies may be subject to general principles of equity (whether considered in a proceeding in equity or at law).
Authorization of Series B Notes. Exhibit A-2;
Authorization of Series B Notes. The Company will authorize the issuance and sale of $40,000,000 aggregate principal amount of its 6.14% Senior Notes, Series B, due May 16, 2016 (the “Series B Notes”), to be dated the date of issue, to bear interest from such date at the rate of 6.14% per annum, payable semi-annually, on the 16th day of each May and November in each year (commencing November 16, 2006) and at maturity and to bear interest on overdue principal (including any overdue prepayment of principal) and premium, if any, and (to the extent legally enforceable) on any overdue installment of interest at the rate per annum from time to time equal to the greater of (i) 8.14% or (ii) 2% over the rate of interest publicly announced by U.S. Bank National Association from time to time in Milwaukee, Wisconsin as its “base” or “prime” rate. The Series B Notes will mature on May 16, 2016 and will be substantially in the form of Exhibit 1 attached to this Series B Terms Agreement. The term “Series B Note” as used herein shall include any and all of the 6.14% Series B Notes delivered pursuant to this Series B Terms Agreement and any Series B Notes issued in substitution therefor pursuant to Section 13 of the Agreement.
Authorization of Series B Notes. The Company will authorize the issue of its 6.88% Senior Secured Notes, Series B, due July 1, 2010 (the “Series B Notes”), in the aggregate principal amount of $10,000,000, to be dated the most recent date to which interest has been paid on the Existing Series B Notes, to mature July 1, 2010, to bear interest on the unpaid balance thereof from the date thereof until the principal thereof shall have become due and payable at the rate of 6.88% per annum and on the occurrence and during the continuation of an Event of Default at the rate specified therein, to be substantially in the form of Exhibit A-2 hereto and to be issued upon exchange for the Existing Series B Notes. The term “Series B Notes” as used herein shall include each Series B Note delivered pursuant to any provision of this Agreement and each Series B Note delivered in substitution or exchange for any such Series B Note pursuant to any such provision.
Authorization of Series B Notes. The Issuer has authorized the issue and sale of its Series B Notes (the “Series B Notes”) in the aggregate principal amount of US$25,000,000 to be dated the date of issue thereof, to mature June 29, 2023 to bear interest on the unpaid balance thereof from the date thereof until the principal thereof shall have become due and payable (whether by acceleration or otherwise) at the initial rate of 4.88% per annum (subject to adjustment as provided therein) and on overdue payment at the rate specified therein, and to be substantially in the form of Exhibit 1(b) attached hereto. The terms “Series B Note” and “Series B Notes” as used herein shall include each Series B Note delivered pursuant to any provision of this Agreement and each Series B Note delivered in substitution or exchange for any such Series B Note pursuant to any such provision.
Authorization of Series B Notes. Under the Existing Agreement the Company authorized and issued its 6.88% Senior Secured Notes, Series B, due July 1, 2010 (the “Series B Notes”), in the aggregate principal amount of $10,000,000. The Series B Notes mature July 1, 2010, bear interest on the unpaid balance thereof from the date thereof until the principal thereof shall have become due and payable at the rate of 6.88% per annum and on the occurrence and during the continuation of an Event of Default at the rate specified therein, and are substantially in the form of Exhibit A-2 hereto. The term “Series B Notes” as used herein shall include each Series B Note delivered pursuant to any provision of the Existing Agreement or this Agreement and each Series B Note delivered in substitution or exchange for any such Series B Note pursuant to any such provision.
Authorization of Series B Notes. The Company will authorize the issue and sale of $30,000,000 aggregate principal amount of its 6.69% Series B Senior Notes due July 31, 2008 (the "Series B Notes," such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements).
Authorization of Series B Notes. The Series B Notes have been duly authorized by the Company and, when issued in the Registered Exchange Offer, will have been validly executed, authenticated, issued and delivered in accordance with the terms of the Indenture, the Registration Rights Agreement and the Registered Exchange Offer and will be legal, valid and binding obligations of the Company, entitled to the benefits of the Indenture and enforceable against the Company in accordance with their terms, except that such enforceability may be limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditor’s rights generally, and by general equitable principles (whether considered in a proceeding in equity or at law). The Series B Notes, when issued, authenticated and delivered, will conform in all material respects to the description thereof in the Time of Sale Document and the Final Offering Memorandum.
